Shares of Carl Zeiss Meditec AG (ETR:AFX - Get Free Report) dropped 0.5% during mid-day trading on Thursday . The company traded as low as €56.90 ($59.89) and last traded at €56.90 ($59.89). Approximately 107,944 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 94,405 shares. The stock had previously closed at €57.20 ($60.21).
Carl Zeiss Meditec Stock Down 4.0 %
The business has a 50-day moving average price of €61.53 and a 200-day moving average price of €68.62. The firm has a market capitalization of $4.89 billion, a PE ratio of 23.97, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98. The company has a quick ratio of 2.47, a current ratio of 3.51 and a debt-to-equity ratio of 6.74.
Carl Zeiss Meditec Company Profile
(
Get Free Report)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
See Also
Before you consider Carl Zeiss Meditec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.
While Carl Zeiss Meditec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
